Volume | 209 580 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 1,55 | Bas Haut |
|||||
Minimum Bas | 1,32 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
NKGen Biotech Inc | NKGN | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,33 | 1,32 | 1,55 | 1,43 | 1,32 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
1 375 | 209 580 | US$ 1,42 | US$ 297 614 | - | 0,7802 - 6,70 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
01:30:11 | 15 | US$ 1,40 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
31,08M | 21,89M | - | 0 | -82,95M | -3,79 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action NKGen Biotech
Date | Heure | Source | Titre |
---|---|---|---|
22/2/2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
15/2/2024 | 02:19 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
15/2/2024 | 02:16 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
15/2/2024 | 02:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
15/2/2024 | 02:11 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
14/2/2024 | 19:05 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
22/1/2024 | 12:12 | Edgar (US Regulatory) | Form 8-K - Current report |
08/1/2024 | 23:19 | Edgar (US Regulatory) | Form 8-K - Current report |
28/12/2023 | 22:14 | Edgar (US Regulatory) | Form 8-K - Current report |
27/12/2023 | 22:02 | Edgar (US Regulatory) | Form 8-K - Current report |
27/12/2023 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report |
19/12/2023 | 19:41 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
Forum Action NKGen Biotech
Aucune Discussion TrouvéeAjouter une Discussion
Historiques NKGen Biotech Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 1,90 | 1,95 | 1,28 | 1,60 | 928 087 | -0,47 | -24,74% |
1 mois | 1,23 | 2,11 | 0,821 | 1,55 | 2 500 689 | 0,20 | 16,26% |
3 mois | 1,61 | 4,06 | 0,7802 | 1,85 | 3 877 186 | -0,18 | -11,18% |
6 mois | 3,06 | 4,06 | 0,7802 | 1,88 | 1 854 237 | -1,63 | -53,27% |
1 an | 5,98 | 6,70 | 0,7802 | 1,93 | 1 607 992 | -4,55 | -76,09% |
3 ans | 5,98 | 6,70 | 0,7802 | 1,93 | 1 607 992 | -4,55 | -76,09% |
5 ans | 5,98 | 6,70 | 0,7802 | 1,93 | 1 607 992 | -4,55 | -76,09% |